Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
- 1 April 2005
- journal article
- clinical trial
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 20 (3), 203-205
- https://doi.org/10.1002/hup.682
Abstract
This is a report on a case series of five patients with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10-20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen.Keywords
This publication has 11 references indexed in Scilit:
- Ziprasidone‐related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challengeHuman Psychopharmacology: Clinical and Experimental, 2004
- Ziprasidone in Parkinson's Disease PsychosisThe Canadian Journal of Psychiatry, 2004
- Psychosis in Parkinson's diseaseMovement Disorders, 2003
- Pharmacodynamics of Ziprasidone in Children and Adolescents: Impact on Dopamine TransmissionJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Treatment of Psychosis in Parkinson???s DiseaseDrug Safety, 2003
- Intramuscular Preparations of AntipsychoticsDrugs, 2003
- Olanzapine and clozapineNeurology, 2000
- QuetiapineCNS Drugs, 2000
- Clozapine in drug-induced psychosis in Parkinson's diseaseThe Lancet, 1999
- Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's DiseaseNew England Journal of Medicine, 1999